Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Liver Diseases

  Free Subscription


Articles published in AJR Am J Roentgenol

Retrieve available abstracts of 84 articles:
HTML format



Single Articles


    November 2021
  1. GUO Z, Blake GM, Graffy PM, Sandfort V, et al
    Hepatic Steatosis: CT-based Prevalence in Adults in China and the United States and Associations with Age, Sex, and Body Mass Index.
    AJR Am J Roentgenol. 2021 Nov 24. doi: 10.2214/AJR.21.26728.
    PubMed     Abstract available


  2. RONG D, He B, Tang W, Xie S, et al
    Comparison of Gadobenate-Enhanced MRI and Gadoxetate-Enhanced MRI for Hepatocellular Carcinoma Detection Using LI-RADS Version 2018: A Prospective Intraindividual Randomized Study.
    AJR Am J Roentgenol. 2021 Nov 24. doi: 10.2214/AJR.21.26818.
    PubMed     Abstract available


    October 2021
  3. HAO F, Eghbalieh N, So A, Lee EW, et al
    Hepatic Plexus Nerve Block for Microwave Ablation of Hepatic Tumors.
    AJR Am J Roentgenol. 2021 Oct 27. doi: 10.2214/AJR.21.26779.
    PubMed     Abstract available


  4. STRUYCKEN L, Patel M, Kuo P, Hennemeyer C, et al
    Clinical and Dosimetric Implications of Calculating Lung Shunt Fraction for Hepatic Yttrium-90 Radioembolization Using SPECT/CT Versus Planar Scintigraphy.
    AJR Am J Roentgenol. 2021 Oct 27. doi: 10.2214/AJR.21.26663.
    PubMed     Abstract available


  5. CHERNYAK V
    Editorial Comment: Transitional or Hepatobiliary Phase Hypointensity Improves Sensitivity Without Loss of Specificity for Pathologically Viable HCC After Locoregional Treatment.
    AJR Am J Roentgenol. 2021 Oct 20. doi: 10.2214/AJR.21.26949.
    PubMed    


  6. CHERNYAK V, van der Pol CB, Vernuccio F, Yoshimitsu K, et al
    The Global Reading Room: Imaging Detection of Hepatocellular Carcinoma.
    AJR Am J Roentgenol. 2021 Oct 13. doi: 10.2214/AJR.21.26909.
    PubMed    


  7. RANATHUNGA D, Osman H, Islam N, McInnes MD, et al
    Progression Rates of LR-2 and LR-3 Observations on MRI to Higher LI-RADS Categories in Patients at High Risk for Hepatocellular Carcinoma: A Retrospective Study.
    AJR Am J Roentgenol. 2021 Oct 13. doi: 10.2214/AJR.21.26376.
    PubMed     Abstract available


  8. LIU J, Ma J, Yang C, Ye T, et al
    Reply to "Factors in Spleen Size After TIPS Placement".
    AJR Am J Roentgenol. 2021;217:1013.
    PubMed    


  9. GEMERY JM, Munger DP, Hoffer EK
    Factors in Spleen Size After TIPS Placement.
    AJR Am J Roentgenol. 2021;217:1013.
    PubMed    


  10. FERRAIOLI G
    Beyond the AJR: "Two-Dimensional Shear Wave Elastography Predicts Survival in Advanced Chronic Liver Disease".
    AJR Am J Roentgenol. 2021;217:1012.
    PubMed    


    September 2021
  11. DOHARE N, Madhusudhan KS, Malik R, Das P, et al
    Utility of Hepatic 2D Shear-Wave Elastography in Monitoring Response to Image-Guided Intervention in Children With Chronic Budd-Chiari Syndrome: A Prospective Study.
    AJR Am J Roentgenol. 2021 Sep 29. doi: 10.2214/AJR.21.26547.
    PubMed     Abstract available


  12. KIM YY, Kim MJ, Yoon JK, Shin J, et al
    Incorporation of Ancillary MRI Features into the LI-RADS Treatment Response Algorithm: Impact on Diagnostic Performance After Locoregional Treatment for Hepatocellular Carcinoma.
    AJR Am J Roentgenol. 2021 Sep 29. doi: 10.2214/AJR.21.26677.
    PubMed     Abstract available


  13. REIZINE E, Chalaye J, Mule S, Regnault H, et al
    Utility of Early Posttreatment PET/CT Evaluation Using FDG or (18)F-FCH to Predict Response to (90)Y Radioembolization in Patients With Hepatocellular Carcinoma.
    AJR Am J Roentgenol. 2021 Sep 8. doi: 10.2214/AJR.21.26485.
    PubMed     Abstract available


    August 2021
  14. SHARBIDRE KG
    Editorial Comment: Recurrence of Hepatocellular Carcinoma in Liver Transplants-Microvascular Invasion and Pathologic Staging of the Explant Liver.
    AJR Am J Roentgenol. 2021 Aug 18. doi: 10.2214/AJR.21.26681.
    PubMed    


  15. CUNHA GM, Hosseini M, Furlan A, Fowler K, et al
    Hepatocellular Carcinoma Staging: Differences Between Radiologic and Pathologic Systems and Relevance to Patient Selection and Outcomes in Liver Transplantation.
    AJR Am J Roentgenol. 2021 Aug 18. doi: 10.2214/AJR.21.26436.
    PubMed     Abstract available


    July 2021
  16. SEVCO TJ, Masch WR, Maturen KE, Mendiratta-Lala M, et al
    Ultrasound (US) LI-RADS: Outcomes of Category US-3 Observations.
    AJR Am J Roentgenol. 2021 Jul 14:1-7. doi: 10.2214/AJR.20.23447.
    PubMed     Abstract available


  17. PAUL RK, Vazirani R, McDermott JC, Kliewer MA, et al
    Identification of the Most Important Subset of Doppler, Laboratory, and Clinical Parameters for Serial TIPS Evaluation.
    AJR Am J Roentgenol. 2021;217:164-171.
    PubMed     Abstract available


    June 2021
  18. CHU HH, Kim JH, Shin YM, Won HJ, et al
    Percutaneous Radiofrequency Ablation for Recurrent Intrahepatic Cholangiocarcinoma After Curative Resection: Multivariable Analysis of Factors Predicting Survival Outcomes.
    AJR Am J Roentgenol. 2021 Jun 2:1-7. doi: 10.2214/AJR.20.23461.
    PubMed     Abstract available


  19. ARAKI T, Imaizumi A, Okada H, Sasaki Y, et al
    Anatomy of Left Inferior Phrenic Vein in Patients Without Portal Hypertension.
    AJR Am J Roentgenol. 2021 Jun 2:1-7. doi: 10.2214/AJR.20.23106.
    PubMed     Abstract available


    May 2021
  20. RIDDELL AM, Torkzad MR, Koh DM
    Reply to "Additional Considerations on Use of Abbreviated Liver MRI in Patients With Colorectal Liver Metastases".
    AJR Am J Roentgenol. 2021 May 19:W1-W2. doi: 10.2214/AJR.21.25747.
    PubMed    


  21. GRANATA V, Fusco R, Petrillo A
    Additional Considerations on Use of Abbreviated Liver MRI in Patients With Colorectal Liver Metastases.
    AJR Am J Roentgenol. 2021 May 19:W1. doi: 10.2214/AJR.21.25652.
    PubMed    


  22. MALONE CD
    Editorial Comment on "Ultrasound-Guided Portal Vein Access and Percutaneous Wire Placement in the Portal Vein Are Associated With Shorter Procedure Times and Lower Radiation Doses During TIPS Placement".
    AJR Am J Roentgenol. 2021;216:1299.
    PubMed    


    April 2021
  23. ROBBINS AJ, Ritter S, Markese M, Skube ME, et al
    Atypical Hepatic Steatosis Patterns on MRI After Total Pancreatectomy With Islet Autotransplant.
    AJR Am J Roentgenol. 2021 Apr 28:1-7. doi: 10.2214/AJR.20.23303.
    PubMed     Abstract available


  24. CHAVHAN GB, Yoo SJ, Lam CZ, Khanna G, et al
    Abdominal Imaging of Children and Young Adults With Fontan Circulation: Pathophysiology and Surveillance.
    AJR Am J Roentgenol. 2021 Apr 28:1-11. doi: 10.2214/AJR.20.23404.
    PubMed     Abstract available


  25. SQUIRES JH, McCarville MB
    Contrast-Enhanced Ultrasound in Children: Implementation and Key Diagnostic Applications.
    AJR Am J Roentgenol. 2021 Apr 28. doi: 10.2214/AJR.21.25713.
    PubMed     Abstract available


  26. KIM B, Won JH, Kim J, Kwon Y, et al
    Hepatic Arterial Infusion Chemotherapy for Advanced Hepatocellular Carcinoma: Radiologic and Clinical Factors Predictive of Survival.
    AJR Am J Roentgenol. 2021 Apr 14:1-8. doi: 10.2214/AJR.20.23213.
    PubMed     Abstract available


  27. CHEN Y, Xia Y, Tolat PP, Long L, et al
    Comparison of Conventional Gadoxetate Disodium-Enhanced MRI Features and Radiomics Signatures With Machine Learning for Diagnosing Microvascular Invasion.
    AJR Am J Roentgenol. 2021 Apr 7:1-11. doi: 10.2214/AJR.20.23255.
    PubMed     Abstract available


  28. FERRAIOLI G, Barr RG
    Quantification of Liver Steatosis: Is CT Equivalent to PDFF?
    AJR Am J Roentgenol. 2021;216:W14.
    PubMed    


  29. CORNMAN-HOMONOFF J, Madoff DC
    Commentary on: "Rebleeding and Mortality Risk Are Increased by ACLF but Reduced by Pre-emptive TIPS".
    AJR Am J Roentgenol. 2021;216:878.
    PubMed    


    March 2021
  30. YOUNG S, Cam I, Gencturk M
    Reply to "Utility of Ultrasound Guidance During Direct Intrahepatic Portal Shunt Placement in Pediatric Patients With Budd-Chiari Syndrome".
    AJR Am J Roentgenol. 2021 Mar 24:W1. doi: 10.2214/AJR.20.24769.
    PubMed    


  31. LUDWIG DR, Fraum TJ, Ballard DH, Narra VR, et al
    Imaging Biomarkers of Hepatic Fibrosis: Reliability and Accuracy of Hepatic Periportal Space Widening and Other Morphologic Features on MRI.
    AJR Am J Roentgenol. 2021 Mar 17:1-11. doi: 10.2214/AJR.20.23099.
    PubMed     Abstract available


  32. MADHUSUDHAN KS, Sharma S
    Utility of Ultrasound Guidance During Direct Intrahepatic Portal Shunt Placement in Pediatric Patients With Budd-Chiari Syndrome.
    AJR Am J Roentgenol. 2021 Mar 17:W1. doi: 10.2214/AJR.20.24556.
    PubMed    


  33. SARWAR A, Esparaz AM, Chakrala N, Mangano M, et al
    Efficacy of TIPS Reduction for Refractory Hepatic Encephalopathy, Right Heart Failure, and Liver Dysfunction.
    AJR Am J Roentgenol. 2021 Mar 11:1-6. doi: 10.2214/AJR.19.22497.
    PubMed     Abstract available


  34. LOKKEN RP, Kerlan RK , Jr, Chung YC, Chen YF, et al
    Hepatic Toxicity After Selective Chemoembolization Is Associated With Decreased Survival Among Patients With Hepatocellular Carcinoma.
    AJR Am J Roentgenol. 2021 Mar 11:1-8. doi: 10.2214/AJR.20.23478.
    PubMed     Abstract available


  35. WANG Y, Liang W
    Quality Control of Radiomics Study to Differentiate Benign and Malignant Hepatic Lesions.
    AJR Am J Roentgenol. 2021;216:W12.
    PubMed    


  36. HOMAYOUNIEH F, Kalra MK
    Reply to "Quality Control of Radiomics Study to Differentiate Benign and Malignant Hepatic Lesions".
    AJR Am J Roentgenol. 2021;216:W13.
    PubMed    


  37. LEE GM, Stowell JT, Pope K, Carter BW, et al
    Lymphatic Pathways of the Thorax: Predictable Patterns of Spread.
    AJR Am J Roentgenol. 2021;216:649-658.
    PubMed     Abstract available


    February 2021
  38. WU V, Li MD, Goodwin JS, Wehrenberg-Klee EP, et al
    Yttrium-90 Hepatic Radioembolization for Advanced Chemorefractory Metastatic Colorectal Cancer: Survival Outcomes Based on Right-Versus Left-Sided Primary Tumor Location.
    AJR Am J Roentgenol. 2021 Feb 17. doi: 10.2214/AJR.20.25315.
    PubMed     Abstract available


  39. RIEDESEL EL
    Editorial Comment: Liver Fat Quantification by Ultrasound-Potential to Change Diagnosis and Management of Pediatric NAFLD.
    AJR Am J Roentgenol. 2021 Feb 10. doi: 10.2214/AJR.21.25594.
    PubMed    


  40. VAN DER POL CB, Dhindsa K, Shergill R, Zha N, et al
    MRI Liver Imaging Reporting and Data System (LI-RADS) Version 2018: Impact of and Reduction in Ancillary Features.
    AJR Am J Roentgenol. 2021 Feb 3:1-8. doi: 10.2214/AJR.20.23031.
    PubMed     Abstract available


  41. MARKS RM, Masch WR, Chernyak V
    LI-RADS: Past, Present, and Future, From the AJR Special Series on Radiology Reporting and Data Systems.
    AJR Am J Roentgenol. 2021;216:295-304.
    PubMed     Abstract available


    January 2021
  42. TORKZAD MR, Riddell AM, Chau I, Cunningham D, et al
    Clinical Performance of Abbreviated Liver MRI for the Follow-Up of Patients With Colorectal Liver Metastases.
    AJR Am J Roentgenol. 2021 Jan 27:1-8. doi: 10.2214/AJR.20.22854.
    PubMed     Abstract available


  43. LUBNER MG, Graffy PM, Said A, Watson R, et al
    Utility of Multiparametric CT for Identification of High-Risk NAFLD.
    AJR Am J Roentgenol. 2021 Jan 21:1-10. doi: 10.2214/AJR.20.22842.
    PubMed     Abstract available


  44. BUROS C, Furlan A
    Beyond the AJR: "Magnetic Resonance Elastography versus Transient Elastography in the Prediction of Complications after Resection for Hepatocellular Carcinoma".
    AJR Am J Roentgenol. 2021 Jan 20. doi: 10.2214/AJR.21.25458.
    PubMed    


  45. BAIKPOUR M, Ozturk A, Dhyani M, Mercaldo ND, et al
    Reply to "Biomarkers for High-Risk Nonalcoholic Fatty Liver Disease: Beyond Portal Venous Pulsatility Index".
    AJR Am J Roentgenol. 2021;216:W2.
    PubMed    


  46. LIZARAZO DA, Romero J, Gonzalez-Gomez S
    Biomarkers for High-Risk Nonalcoholic Fatty Liver Disease: Beyond Portal Venous Pulsatility Index.
    AJR Am J Roentgenol. 2021;216:W1.
    PubMed    


    December 2020
  47. BOYUM JH, Sheedy SP, Graham RP, Olson JT, et al
    Hepatic Mucinous Cystic Neoplasm Versus Simple Biliary Cyst: Assessment of Distinguishing Imaging Features Using CT and MRI.
    AJR Am J Roentgenol. 2020 Dec 23:1-9. doi: 10.2214/AJR.20.22768.
    PubMed     Abstract available


  48. KINNEY TB
    Editorial Comment: A Cautionary Experience with Drug-Eluting Beads Transarterial Chemoembolization for Hepatocellular Carcinoma.
    AJR Am J Roentgenol. 2020 Dec 23. doi: 10.2214/AJR.20.25284.
    PubMed    


  49. YANG Q, Cai Q, Wen H, Mao Y, et al
    The CT and MRI Features of Primary Intrahepatic Lymphoepithelioma-Like Cholangiocarcinoma.
    AJR Am J Roentgenol. 2020 Dec 16:1-10. doi: 10.2214/AJR.20.22937.
    PubMed     Abstract available


  50. RENTON M, Kielar A
    Beyond the AJR: "Gadoxetic acid-enhanced MRI of macrotrabecular-massive hepatocellular carcinoma and its prognostic implications".
    AJR Am J Roentgenol. 2020 Dec 9. doi: 10.2214/AJR.20.25188.
    PubMed    


  51. CHENG J, Qiu M, Zhang Y, Hong N, et al
    Enhanced Rim on MDCT of Colorectal Liver Metastases: Assessment of Ability to Predict Progression-Free Survival and Response to Bevacizumab-Based Chemotherapy.
    AJR Am J Roentgenol. 2020;215:1377-1383.
    PubMed     Abstract available


    November 2020
  52. ZHANG L, Sun JH, Ji JS, Zhong BY, et al
    Imaging Changes and Clinical Complications After Drug-Eluting Beads Versus Conventional Transarterial Chemoembolization for Unresectable Hepatocellular Carcinoma: Multicenter Study.
    AJR Am J Roentgenol. 2020 Nov 27. doi: 10.2214/AJR.20.24708.
    PubMed     Abstract available


    October 2020
  53. KIM YY, Choi JY, Kim SU, Lee M, et al
    MRI Ancillary Features for LI-RADS Category 3 and 4 Observations: Improved Categorization to Indicate the Risk of Hepatic Malignancy.
    AJR Am J Roentgenol. 2020 Oct 14:1-9. doi: 10.2214/AJR.20.22802.
    PubMed     Abstract available


  54. STRNAD BS, Ludwig DR, Gilcrease-Garcia B, Fraum TJ, et al
    Contemporary Imaging of the Surgically Placed Hepatic Arterial Infusion Chemotherapy Pump.
    AJR Am J Roentgenol. 2020 Oct 7. doi: 10.2214/AJR.20.24437.
    PubMed     Abstract available


  55. KEE-SAMPSON J
    Editorial Comment on "Thermal Ablation Versus Stereotactic Body Radiotherapy Following Transarterial Chemoembolization for Inoperable Hepatocellular Carcinoma: A Propensity Score Weighted Analysis".
    AJR Am J Roentgenol. 2020 Oct 7. doi: 10.2214/AJR.20.24849.
    PubMed    


    September 2020
  56. NABAVIZADEH N, Jahangiri Y, Rahmani R, Tomozawa Y, et al
    Thermal Ablation Versus Stereotactic Body Radiotherapy Following Transarterial Chemoembolization for Inoperable Hepatocellular Carcinoma: A Propensity Score Weighted Analysis.
    AJR Am J Roentgenol. 2020 Sep 30. doi: 10.2214/AJR.20.24117.
    PubMed     Abstract available


  57. BORHANI AA
    Editorial Comment on "Liver Steatosis Categorization on Contrast-Enhanced CT Using a Fully-Automated Deep Learning Volumetric Segmentation Tool: Evaluation in 1,204 Heathy Adults Using Unenhanced CT as Reference Standard".
    AJR Am J Roentgenol. 2020 Sep 30. doi: 10.2214/AJR.20.24764.
    PubMed    


  58. PICKHARDT PJ, Blake GM, Graffy PM, Sandfort V, et al
    Liver Steatosis Categorization on Contrast-Enhanced CT Using a Fully-Automated Deep Learning Volumetric Segmentation Tool: Evaluation in 1,204 Heathy Adults Using Unenhanced CT as Reference Standard.
    AJR Am J Roentgenol. 2020 Sep 16. doi: 10.2214/AJR.20.24415.
    PubMed     Abstract available


  59. MICHELL H, Johnston GP, Chopra P, Scriver GM, et al
    Cholecystostomy as an Exclusive Access to Remove Cystic, Common Hepatic, and Common Bile Duct Stones.
    AJR Am J Roentgenol. 2020 Sep 9:1-5. doi: 10.2214/AJR.19.22469.
    PubMed     Abstract available


  60. PHAM JT, Kalantari J, Ji C, Chang JH, et al
    Quantitative CT Predictors of Portal Venous Intervention in Uncontrolled Variceal Bleeding.
    AJR Am J Roentgenol. 2020 Sep 9:1-5. doi: 10.2214/AJR.19.22460.
    PubMed     Abstract available


  61. KIERANS AS, Song C, Gavlin A, Roudenko A, et al
    Diagnostic Performance of LI-RADS Version 2018, LI-RADS Version 2017, and OPTN Criteria for Hepatocellular Carcinoma.
    AJR Am J Roentgenol. 2020 Sep 2:1-8. doi: 10.2214/AJR.20.22772.
    PubMed     Abstract available


  62. ANDREWS JC
    Editorial Comment on "Retrospective Comparison of Clinical Outcomes Following Splenic Vein Stenting and Splenic Arterial Embolization in Sinistral Portal Hypertension-Related Gastrointestinal Bleeding".
    AJR Am J Roentgenol. 2020 Sep 2. doi: 10.2214/AJR.20.24486.
    PubMed    


  63. MONTI L, Salsano M, Candusso M, Avolio AW, et al
    Diagnosis of Acute Rejection of Liver Grafts in Young Children Using Acoustic Radiation Force Impulse Imaging.
    AJR Am J Roentgenol. 2020 Sep 2:1-9. doi: 10.2214/AJR.19.22057.
    PubMed     Abstract available


    August 2020
  64. WEI B, Zhang L, Tong H, Wang Z, et al
    Retrospective Comparison of Clinical Outcomes Following Splenic Vein Stenting and Splenic Arterial Embolization in Sinistral Portal Hypertension-Related Gastrointestinal Bleeding.
    AJR Am J Roentgenol. 2020 Aug 26. doi: 10.2214/AJR.20.23859.
    PubMed     Abstract available


  65. OLSON MC, Venkatesh SK
    HCC Screening: Is Ultrasound Still Needed at Transplant Centers?-Counterpoint: No, CT/MR is the Way to Go.
    AJR Am J Roentgenol. 2020 Aug 19. doi: 10.2214/AJR.20.24252.
    PubMed    


  66. KAMAYA A, Rodgers SK
    HCC Screening: Is Ultrasound Still Needed at Transplant Centers?-Point: Yes, Ultrasound Remains First Line.
    AJR Am J Roentgenol. 2020 Aug 19. doi: 10.2214/AJR.20.24382.
    PubMed    


  67. BORRERO R, Valencia S, Triana G
    Are Cutoff Points of Liver Fibrosis in Shear Wave Elastography Really Reliable to Determine Whether Patients Should Undergo Biopsy?
    AJR Am J Roentgenol. 2020;215:W29.
    PubMed    


    July 2020
  68. MANCHEC B, Pham E, Noor M, Pepe J, et al
    Contrast-Enhanced CT May Identify High-Risk Esophageal Varices in Patients With Cirrhosis.
    AJR Am J Roentgenol. 2020 Jul 1:1-7. doi: 10.2214/AJR.19.22474.
    PubMed     Abstract available


  69. KIM SW, Kim YR, Choi KH, Cho EY, et al
    Staging of Liver Fibrosis by Means of Semiautomatic Measurement of Liver Surface Nodularity in MRI.
    AJR Am J Roentgenol. 2020 Jul 1:1-7. doi: 10.2214/AJR.19.22041.
    PubMed     Abstract available


    June 2020
  70. CHU HH, Gwon DI, Kim JH, Ko GY, et al
    Drug-Eluting Microsphere Versus Cisplatin-Based Transarterial Chemoembolization for the Treatment of Hepatocellular Carcinoma: Propensity Score-Matched Analysis.
    AJR Am J Roentgenol. 2020 Jun 22:1-8. doi: 10.2214/AJR.19.21669.
    PubMed     Abstract available


    May 2020
  71. YOUNG S, Rostambeigi N, Golzarian J, Lim N, et al
    MELD or Sodium MELD: A Comparison of the Ability of Two Scoring Systems to Predict Outcomes After Transjugular Intrahepatic Portosystemic Shunt Placement.
    AJR Am J Roentgenol. 2020 May 20:1-8. doi: 10.2214/AJR.19.21726.
    PubMed     Abstract available


  72. SMEREKA P, Doshi AM, Lavelle LP, Shanbhogue K, et al
    New Arterial Phase Enhancing Nodules on MRI of Cirrhotic Liver: Risk of Progression to Hepatocellular Carcinoma and Implications for LI-RADS Classification.
    AJR Am J Roentgenol. 2020 May 20:1-8. doi: 10.2214/AJR.19.22033.
    PubMed     Abstract available


  73. HOMAYOUNIEH F, Singh R, Nitiwarangkul C, Lades F, et al
    Semiautomatic Segmentation and Radiomics for Dual-Energy CT: A Pilot Study to Differentiate Benign and Malignant Hepatic Lesions.
    AJR Am J Roentgenol. 2020 May 14:1-8. doi: 10.2214/AJR.19.22164.
    PubMed     Abstract available


  74. SARWAR A, Weinstein JL, Novack V, Chakrala N, et al
    Causes and Rates of 30-Day Readmissions After Transjugular Intrahepatic Portosystemic Shunts.
    AJR Am J Roentgenol. 2020 May 6:1-7. doi: 10.2214/AJR.19.21732.
    PubMed     Abstract available


  75. DRESCHER R, Kuhnel C, Seifert P, Guhne F, et al
    Renal and Intestinal Excretion of (90)Y and (166)Ho After Transarterial Radioembolization of Liver Tumors.
    AJR Am J Roentgenol. 2020;214:1158-1164.
    PubMed     Abstract available


    April 2020
  76. YOUNG S, Golzarain J
    Locoregional Therapies in the Treatment of 3- to 5-cm Hepatocellular Carcinoma: Critical Review of the Literature.
    AJR Am J Roentgenol. 2020 Apr 7:1-12. doi: 10.2214/AJR.19.22098.
    PubMed     Abstract available


  77. BAIKPOUR M, Ozturk A, Dhyani M, Mercaldo ND, et al
    Portal Venous Pulsatility Index: A Novel Biomarker for Diagnosis of High-Risk Nonalcoholic Fatty Liver Disease.
    AJR Am J Roentgenol. 2020;214:786-791.
    PubMed     Abstract available


    March 2020
  78. WANG DC, Jang HJ, Kim TK
    Characterization of Indeterminate Liver Lesions on CT and MRI With Contrast-Enhanced Ultrasound: What Is the Evidence?
    AJR Am J Roentgenol. 2020 Mar 17:1-10. doi: 10.2214/AJR.19.21498.
    PubMed     Abstract available


  79. ROMBERG EK, Tang ER, Chandra T, Podberesky DJ, et al
    Applications of Pediatric Body CT Angiography: What Radiologists Need to Know.
    AJR Am J Roentgenol. 2020 Mar 4:1-12. doi: 10.2214/AJR.19.22274.
    PubMed     Abstract available


    January 2020
  80. EL-ALI AM, McCormick A, Thakrar D, Yilmaz S, et al
    Contrast-Enhanced Ultrasound of Congenital and Infantile Hemangiomas: Preliminary Results From a Case Series.
    AJR Am J Roentgenol. 2020 Jan 22:1-7. doi: 10.2214/AJR.19.22174.
    PubMed     Abstract available


  81. FURLAN A, Tublin ME, Yu L, Chopra KB, et al
    Comparison of 2D Shear Wave Elastography, Transient Elastography, and MR Elastography for the Diagnosis of Fibrosis in Patients With Nonalcoholic Fatty Liver Disease.
    AJR Am J Roentgenol. 2020;214:W20-W26.
    PubMed     Abstract available


    October 2019
  82. KOHNO S, Isoda H, Ono A, Furuta A, et al
    Portal Vein Embolization: Radiological Findings Predicting Future Liver Remnant Hypertrophy.
    AJR Am J Roentgenol. 2019 Oct 23:1-7. doi: 10.2214/AJR.19.21440.
    PubMed     Abstract available


  83. CONSUL N, Menias CO, Lubner MG, Katabathina VS, et al
    A Review of Viral-Related Malignancies and the Associated Imaging Findings.
    AJR Am J Roentgenol. 2019 Oct 8:1-10. doi: 10.2214/AJR.19.21357.
    PubMed     Abstract available


  84. CHUNG JW, Yu JS, Choi JM, Cho ES, et al
    Subtraction Images From Portal Venous Phase Gadoxetic Acid-Enhanced MRI for Observing Washout and Enhancing Capsule Features in LI-RADS Version 2018.
    AJR Am J Roentgenol. 2019 Oct 1:1-9. doi: 10.2214/AJR.18.20797.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Liver Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: